Chromosome X houses a mutation in gene G6PD, IKBKG (glucose-6-phosphate dehydrogenase| inhibitor of nuclear factor kappa B kinase regulatory subunit gamma). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any?
Pathogenic; Anemia, nonspherocytic hemolytic, due to G6PD deficiency